Abstract
Fourteen combat veterans completed a 9-week open trial of nefazodone for treatment of posttraumatic stress disorder (PTSD). Overall PTSD symptoms as measured by the Clinician-Administered PTSD Scale (CAPS) showed a modest but statistically significant decrease with nefazodone treatment. Decreases in CAPS reexperiencing and avoidance, but not hyperarousal symptoms, approached statistical significance. Anxiety decreased significantly, and there were trends toward decreased depression and anger on structured assessments. This study adds to the clinical evidence that nefazodone may be helpful for the management of PTSD symptoms.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Armitage, R., Rush, A. J., & Trivedi, M. et al. (1994). The effects of nefazodone on sleep architecture in depression. Neuropsychopharmacology, 10, 123–127.
Blake, D. D., Weathers, F.W., & Nagy, L.M. et al. (1995). The development of a clinician-administered PTSD scale. Journal of Traumatic Stress, 8, 75–80.
Brady, K., Pearlstein, T., Asnis, G. M., Baker, D., Rothbaum, B., Sikes, C. R., & Farfel, G. M. (2000). Efficacy and safety of sertraline treatment of posttraumatic stress disorder: A randomized controlled trial. JAMA, 283, 1837–1844.
Brophy, M. H. (1991). Cyproheptadine for combat nightmares in posttraumatic stress disorder and dream anxiety disorder. Military Medicine, 156, 100–101.
Davidson, J. (1992). Drug therapy of post-traumatic stress disorder. British Journal of Psychiatry, 160, 309–314.
Davidson, J. R. T., & Fairbank, J. A. (1993). The epidemiology of post-traumatic stress disorder. In J. R. T. Davidson & E. B. Foa (Eds.), Post-traumatic stress disorder: DSM-IV and beyond (pp. 147–169). Washington, DC: American Psychiatric Press.
Davis, L. L., Nugent, A. L., Murray, J., Kramer, G. L., & Petty, F. (2000). Nefazodone treatment for chronic posttraumatic stress disorder: An open trial. Journal of Clinical Psychopharmacology, 20, 159–164.
Di Nardo, P. A., & Barlow, D. H. (1988). Anxiety Disorders Interview Schedule – Revised (ADIS-R).
Eison, A. S., Aison, M. S., & Torrente, J. R. et al. (1990). Nefazodone: Preclinical pharmacology of a new antidepressant. Psychopharmacology Bulletin, 26, 311–315.
Feiger, A., Kiev, A., Shrivastava, R. K., Wisselink, P. G., & Wilcox, C. S. (1996). Nefazodone versus sertraline in outpatients with major depression: Focus on efficacy, tolerability, and effects on sexual function and satisfaction. Journal of Clinical Psychiatry, 57 (Suppl 2), 53–62.
Fichtner, C. G., & Crayton, J. W. (1994). Buspirone in combat-related posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 14, 79–81.
Fichtner, C. G., Poddig, B. E., & de Vito, R. A. (1997). Post-traumatic stress disorder: Pathophysiological aspects and pharmacological approaches to treatment. CNS Drugs, 8, 293–322.
Friedman, M. J., & Southwick, S. M. (1995). Towards pharmacotherapy for posttraumatic stress disorder. In M. J. Friedman, D. S. Charney, & A. Y. Deutch (Eds.), Neurobiological and clinical consequences of stress: From normal adaptation to post-traumatic stress disorder (pp. 465–481). Philadelphia: Lippincott-Raven.
Friedman, M. J., & Yehuda, R. (1995). Post-traumatic stress disorder and comorbidity: Psychobiological approaches to differential diagnosis. In M. J. Friedman, D. S. Charney, & A. Y. Deutch (Eds.), Neurobiological consequences of stress:Fromnormal adaptation to post-traumatic stress disorder. Philadelphia: Lippincott-Raven.
Hamilton, M. (1959). The assessment of anxiety states by rating. British Journal of Medical Psychology, 32, 50–55.
Hamilton, M. (1960).Arating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.
Hertzberg, M. A., Feldman, M. E., Beckham, J. C., & Davidson, J. R. T. (1996). Trial of trazodone for posttraumatic stress disorder using a multiple baseline group design. Journal of Clinical Psychopharmacology, 16, 294–298.
Hertzberg, M. A., Feldman, M. E., Beckham, J. C., Moore, S. D., & Davidson, J. R. T. (1998). Open trial of nefazodone for combat-related posttraumatic stress disorder. Journal of Clinical Psychiatry, 59, 460–464.
Hidalgo, R., Hertzberg, M. A., Mellman, T., Petty, F., Tucker, P., Weisler, R., Zisook, S., Chen, S., Churchill, E., & Davidson, J. (1999). Nefazodone in post-traumatic stress disorder: Results from six open-label trials. International Clinical Psychopharmacology, 14, 61–68.
LaPorta, L. D., & Ware, M. R. (1992). Buspirone in the treatment of posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 12, 133–134.
Marshall, R. D., Schneier, F. R., Fallon, B. A., Knight, C. B. G., Abbate, L. A., Goetz, D., Campeas, R., & Liebowitz, M. R. (1998). An open trial of paroxetine in patients with noncombat-related, chronic posttraumatic stress disorder. Journal of Clinical Psychopharmacology, 18, 10–18.
Sharpley, A. L., Walsh, A. E. S., & Cowen, P. J. (1992). Nefazodone – a novel antidepressant – may increase REM sleep. Biological Psychiatry, 31, 1070–1073.
Sierles, F. S., Chen, J.-J., McFarland, R. E., & Taylor, M. A. (1983). Posttraumatic stress disorder and concurrent psychiatric illness: A preliminary report. American Journal of Psychiatry, 140, 1177–1179.
Spielberger, C.D. (1996). State-trait anger expression inventory. Psychological Assessment Resources.
Spitzer, R. L., & Williams, J. B. W. (1994). Structured Clinical Interview for DSM-IV (SCID). Washington, DC: American Psychiatric Press.
Taylor, D. P., Carter, R. B., & Eison, A. S. et al. (1995). Pharmacology and neurochemistry of nefazodone, a novel antidepressant drug. Journal of Clinical Psychiatry, 56 (Suppl 6), 3–11.
van der Kolk, B. A., Dreyfuss, D., Michaels, M., Shera, D., Berkowitz, R., Fisler, R., & Saxe, G. (1994). Fluoxetine in posttraumatic stress disorder. Journal of Clinical Psychiatry, 55, 517–522.
Wells, B. G., Chu, C.-C., & Johnson, R. et al. (1991). Buspirone in the treatment of posttraumatic stress disorder. Pharmacotherapy, 11, 340–343.
Zisook, S., Chentsova-Dutton, Y. E., Smith-Vaniz, A., Kline, N. A., Ellenor, G. L., Kodsi, A. B., & Gillin, J. C. (2000). Nefazodone in patients with treatment-refractory posttraumatic stress disorder. Journal of Clinical Psychiatry, 61, 203–208.
Author information
Authors and Affiliations
About this article
Cite this article
Garfield, D.A.S., Fichtner, C.G., Leveroni, C. et al. Open Trial of Nefazodone for Combat Veterans with Posttraumatic Stress Disorder. J Trauma Stress 14, 453–460 (2001). https://doi.org/10.1023/A:1011148304140
Issue Date:
DOI: https://doi.org/10.1023/A:1011148304140